Skip to main content
HealthSingle-sourceMedium
5.0

Hepatic Steatosis Prevalence Rising, Redefined as MASLD Systemic Risk

Hepatic steatosis, reclassified as MASLD, is now recognized as a systemic risk marker rather than an isolated ultrasound finding. Estimates suggest about 30% of adults are affected, raising public health concerns. The condition's rising prevalence may drive healthcare costs and policy shifts.

Valor Econômicoabout 8 hours agoBRCredibility 44%View source

Score Breakdown

Mosaic Score5.0
Confidence0.5
Significance0.5
Source credibility0.4
Source

Related signals

8 found